January 19, 2021

Common Antibiotics May Trigger Mental Breakdowns

Evidence suggests doxycycline and other common antibiotics can raise the risk of psychiatric problems, hallucinations, and suicidal thoughts.
January 19, 2021

Americans Making Vaccine Injury Claims Could Face Bureaucratic ‘Black Hole’

Lost in their country’s launch of the coronavirus vaccine is a fact that few Americans realize when they roll up their sleeves. In cases of serious illness from the shots, the injured are blocked from suing and are steered instead to an obscure federal bureaucracy with a record of seldom paying claims.
December 10, 2020

UK Drugs Regulator Forced To Defend Fast Pace Of Pfizer Gene-Based Vaccine Approval

Britain's medicines regulator continues to insist its approval of the Pfizer-BioNTech coronavirus vaccine met all safety standards, after officials in Europe and the United States queried the rapid process.
December 10, 2020

Antiviral Drugs Have No Effect On Mortality In COVID-19

For hospitalized patients with COVID-19, remdesivir, hydroxychloroquine, lopinavir, and interferon regimens seem to have little to no effect on mortality, according to a study published online in the New England Journal of Medicine.
December 3, 2020

Declarations Of Pharma Funding Are Still Not Transparent

Details have been released of money spent last year by drug companies on UK healthcare organizations and doctors.
November 26, 2020

Multibillionaire Warren Buffett Makes Big Investment In US Pharmaceutical Firms

Berkshire Hathaway, the investment company run by multibillionaire Warren Buffet, bought shares in drug companies AbbVie, Bristol-Myers Squibb, Merck and Pfizer between July and September, according to filings with the US regulator.
November 19, 2020

New Study Absurdly Claims Side Effects Of Statin Drugs Are ‘All In The Mind’

A new study claims the side effects reported by patients taking statin drugs are supposedly ‘all in the mind’.
November 19, 2020

Pfizer CEO Sold $5.6 Million Of Stock After His Firm Put Out Vaccine Press Release That Sent Shares Soaring

Pfizer CEO Albert Bourla sold almost $5.6 million worth of stock the same day his company announced data on its experimental coronavirus vaccine that sent shares soaring.